Cerence Narrows FY2026 GAAP EPS Guidance from $(0.07)-$0.15 to $(0.02)-$0.06 vs $0.03 Est; Narrows FY2026 Sales Guidance from $305.000M-$320.000M to $310.000M-$314.000M vs $315.340M Est
Cerence (NASDAQ:CRNC) narrows FY2026 GAAP EPS guidance from $(0.07)-$0.15 to $(0.02)-$0.06 vs $0.03 analyst estimate. Narrows FY2026 sales outlook from $305.000 million-$320.000 million to $310.000 million-$314.000
